Fountain Therapeutics, Inc.
Funding rounds
3 counted as startup funding. Open the number of investors for the round's details.
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
Fountain Therapeutics, Inc. chose not to state its revenue in its newest notice of a funding round (Dec 2021).
SEC Form D · Dec 2021
The industry group it chose in its notices: Biotechnology.
SEC Form D · Dec 2021
Products and services#
No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).
Investors#
No investor of Fountain Therapeutics, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| Thomas Rando | Executive officer | Dec 2021 |
| William Greene | Executive officer | Dec 2021 |
| John Dimos | Executive officer | Feb 2020 |
| Thomas A. Rando | Mr. Rando is the President, Treasurer, Secretary of the Issuer. | Sep 2018 |
| Alex Morgan | Director | Dec 2021 |
| Ashish Khanna | Director | Dec 2021 |
| Thomas Rando | Director | Dec 2021 |
| William Greene | Director | Dec 2021 |
| John Dimos | Director | Feb 2020 |
| Thomas A. Rando | Mr. Rando is the President, Treasurer, Secretary of the Issuer. | Sep 2018 |
| Thomas A. Rando | Mr. Rando is the President, Treasurer, Secretary of the Issuer. | Sep 2018 |